What is the PHAST-TSC Trial?
PHAST-TSC stands for Pre-Hospital Administration of Stroke Therapy –Trans Sodium Crocetinate.
This study will help researchers understand if the drug trans sodium crocetinate (TSC) helps minimize the long term effects of stroke. In the study, TSC will be given to stroke patients through an IV in the arm in the ambulance on the way to the hospital because researchers think it may have the best chance of benefit if given within 2 hours of the start of symptoms of a stroke.
UVA is working with several Emergency Medical Service (EMS) providers and the hospitals that they serve in Charlottesville and Albemarle County. The study is currently enrolling as of August 28th 2019, but we are still meeting with members of the community to let them know about the study and get your feedback.
To learn more about how this study will work, and how subjects will be enrolled in the ambulance, click here:
University of Virginia Department of Neurology
Check out our PI Dr. Andrew Southerland talk about stroke and the PHAST-TSC trial on WINA
We want to hear what you think about the study.
The study team and the local research review board will consider your opinions.